Authors
Fan Yao-Zhu, Shi Li, Wei Guang-Qiang, Li Yu-Fang, Du Wen-Xing, Pu Yi-Quan, Miao Song, Fan Jiang-Ping, Wang Xue-Feng
Published in
Food & function. Nov 17, 2026. Epub Nov 17, 2026.
Abstract
Diabetes and depression exhibit a high rate of comorbidity worldwide, yet traditional drug treatments are often associated with side effects, poor compliance, and limited effectiveness in addressing both conditions simultaneously. Bioactive peptides have emerged as a promising strategy for managing metabolic and emotional disorders due to their high specificity, low toxicity, and multitarget regulatory potential. This review systematically examines the sources, structure-activity relationships, shared mechanisms of action, and potential applications of bioactive peptides with hypoglycemic and antidepressant effects. Hypoglycemic peptides primarily regulate blood glucose by inhibiting enzymes such as α-glucosidase and dipeptidyl peptidase-4 (DPP-IV), whereas antidepressant peptides improve mood by modulating neurotransmitters, neuroplasticity, and anti-inflammatory pathways. These peptides share notable similarities in amino acid composition (e.g., Pro-rich and aromatic-rich motifs), secondary structural motifs (e.g., β-sheet and β-turn conformations), and cyclic architecture, as supported by recent dual-target peptide studies, and converge multiple signaling pathways, including glucagon-like peptide-1 receptor (GLP-1R), brain-derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB), hypothalamic-pituitary-adrenal (HPA) axis, AMP-activated protein kinase (AMPK), phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), and inflammatory pathways, highlighting their potential for multitarget intervention in metabolic-emotional comorbidities. The review further explores the prospects and challenges of applying these peptides in functional foods, drug delivery systems, and personalized nutrition interventions, emphasizing the need for in-depth research on target complexity, delivery system optimization, and clinical translation to advance the practical application of multifunctional peptides in treating comorbid metabolic and emotional disorders.
PMID:
43043628
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0